As reported by 10 News First, as of 1 May 2025 a new ‘game changer’ medication has been listed on Pharmaceutical Benefits Scheme (PBS) to treat an aggressive form of lung cancer most common in...
An evolving technology that can screen for more than 600 different gene fusions (two or more genes joined together) in a single test, has been approved as a diagnostic tool at Monash Health. A study by...
Monash Health is providing renewed hope to cancer patients who do not respond well to chemotherapy. The Monash Health Haematology team has recently developed clinical trial capabilities for studies utilising a form of immunotherapy called CAR-T...
The Monash Health Pathology team’s implementation of pan-cancer genomic testing has put it at the forefront of cancer care and presented staff with a valuable learning opportunity....
Monash Health is looking at new ways to support our adolescent and young adult (AYA) patients with cancer, recognising that their needs differ from those of paediatric and adult patients. Each year, our health service treats...
Lymphoma patients at Monash Health now have an alternative treatment that has fewer side effects compared to standard treatments such as chemotherapy. The drug Glofitamab, which has been given accelerated approval by the US Food and...
Monash Health can now offer autologous stem cell transplantation (ASCT) to some cancer patients. This is a significant milestone for Monash Health as patients no longer need to travel to other healthcare services to receive this...